Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H21N3O6S |
| Molecular Weight | 443.473 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N=CC3=CC=CO3)C4=CC=C(O)C=C4)C(=O)N2[C@H]1C(O)=O
InChI
InChIKey=BWENFVHXWNVVGN-HANWARPLSA-N
InChI=1S/C21H21N3O6S/c1-21(2)16(20(28)29)24-18(27)15(19(24)31-21)23-17(26)14(11-5-7-12(25)8-6-11)22-10-13-4-3-9-30-13/h3-10,14-16,19,25H,1-2H3,(H,23,26)(H,28,29)/b22-10+/t14-,15-,16+,19-/m1/s1
| Molecular Formula | C21H21N3O6S |
| Molecular Weight | 443.473 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.genome.jp/dbget-bin/www_bget?dr:D04270
Sources: https://www.genome.jp/dbget-bin/www_bget?dr:D04270
Fumoxicillin was developed as an antibacterial agent that binds to penicillin-binding protein and inhibits the bacterial cell wall biosynthesis. Information about the current development of this compound is not available.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:45:29 GMT 2025
by
admin
on
Wed Apr 02 08:45:29 GMT 2025
|
| Record UNII |
C7H9M9492J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1500
Created by
admin on Wed Apr 02 08:45:29 GMT 2025 , Edited by admin on Wed Apr 02 08:45:29 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
U-31
Created by
admin on Wed Apr 02 08:45:29 GMT 2025 , Edited by admin on Wed Apr 02 08:45:29 GMT 2025
|
PRIMARY | |||
|
20055356
Created by
admin on Wed Apr 02 08:45:29 GMT 2025 , Edited by admin on Wed Apr 02 08:45:29 GMT 2025
|
PRIMARY | |||
|
SUB07826MIG
Created by
admin on Wed Apr 02 08:45:29 GMT 2025 , Edited by admin on Wed Apr 02 08:45:29 GMT 2025
|
PRIMARY | |||
|
C7H9M9492J
Created by
admin on Wed Apr 02 08:45:29 GMT 2025 , Edited by admin on Wed Apr 02 08:45:29 GMT 2025
|
PRIMARY | |||
|
5128
Created by
admin on Wed Apr 02 08:45:29 GMT 2025 , Edited by admin on Wed Apr 02 08:45:29 GMT 2025
|
PRIMARY | |||
|
DTXSID301024624
Created by
admin on Wed Apr 02 08:45:29 GMT 2025 , Edited by admin on Wed Apr 02 08:45:29 GMT 2025
|
PRIMARY | |||
|
278-865-0
Created by
admin on Wed Apr 02 08:45:29 GMT 2025 , Edited by admin on Wed Apr 02 08:45:29 GMT 2025
|
PRIMARY | |||
|
78186-33-1
Created by
admin on Wed Apr 02 08:45:29 GMT 2025 , Edited by admin on Wed Apr 02 08:45:29 GMT 2025
|
PRIMARY | |||
|
C76223
Created by
admin on Wed Apr 02 08:45:29 GMT 2025 , Edited by admin on Wed Apr 02 08:45:29 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107409
Created by
admin on Wed Apr 02 08:45:29 GMT 2025 , Edited by admin on Wed Apr 02 08:45:29 GMT 2025
|
PRIMARY | |||
|
100000080672
Created by
admin on Wed Apr 02 08:45:29 GMT 2025 , Edited by admin on Wed Apr 02 08:45:29 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |